Carol Fang

Tell us more about your current role at Novartis.

I’m the Global Head of IP – Platforms which means I am an IP strategist who is a trusted advisor and thought partner to the business, focusing on innovations like engineered cell therapy and gene therapy, that can be applied across multiple disease areas.